A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis.

Código QR

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis.

Peginesatide (OMONTYS®) is an erythropoiesis-stimulating agent that was indicated in the United States for the treatment of anemia due to chronic kidney disease in adult patients on dialysis prior to its recent marketing withdrawal by the manufacturer. The objective of this analysis was to develop a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Himanshu Naik, Max C Tsai, Jill Fiedler-Kelly, Ping Qiu, Majid Vakilynejad
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/4b69e4dfd05b48daa768fea949805b53
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
por: Kaushik T, et al.
Publicado: (2013)

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide
por: Valliant A, et al.
Publicado: (2013)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
por: Roganović Maša, et al.
Publicado: (2021)

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
por: Jinhai Wang, et al.
Publicado: (2021)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
por: Andrzej Czyrski, et al.
Publicado: (2021)

Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Jarosław Ruczyński, et al.
Publicado: (2019)

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
por: Persson PB
Publicado: (2015)

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
por: Rambiritch V, et al.
Publicado: (2016)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto K, et al.
Publicado: (2016)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
por: Frost C, et al.
Publicado: (2014)

Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine
por: Lei Yan, et al.
Publicado: (2017)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Amaya L. Bustinduy, et al.
Publicado: (2016)

Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
por: Tarun Kumar Jeloka, et al.
Publicado: (2020)

Pharmacodynamic and pharmacokinetic assessment of pulmonary rehabilitation mixture for the treatment of pulmonary fibrosis
por: Juanjuan Zhao, et al.
Publicado: (2017)

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
por: Frost C, et al.
Publicado: (2018)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
por: Lozano R, et al.
Publicado: (2013)

Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease
por: Yueming Li, et al.
Publicado: (2021)

Chronic dialysis patients with infectious spondylodiscitis have poorer outcomes than non-dialysis populations
por: Kuo G, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model
por: Yuqi Yang, et al.
Publicado: (2021)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
por: Elizabeth C. Randall, et al.
Publicado: (2018)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
por: Frost C, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
por: Nagelschmitz J, et al.
Publicado: (2014)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
por: Cui Y, et al.
Publicado: (2013)

THE LIVED EXPERIENCE OF PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY
por: Tri Hapsari Retno Agustiyowati, et al.
Publicado: (2018)

HYPERURICEMIA IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A SINGLE CENTRE EXPERIENCE
por: Mohsin Qayyum, et al.
Publicado: (2019)

Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem
por: Seonghae Yoon, et al.
Publicado: (2021)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
por: Cui Y, et al.
Publicado: (2014)

Dialysis impact on quality of life of patients with chronic kidney disease in Guatemala. A pilot study
por: B. Halford, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Enrofloxacin Following Single Oral Administration of Different Doses in Brown Trout (<i>Salmo trutta</i>)
por: Kamil Uney, et al.
Publicado: (2021)

Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
por: Hanne Haahr, et al.
Publicado: (2020)

Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague&ndash;Dawley rats
por: Vachon P, et al.
Publicado: (2012)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against <i>Candida auris</i>
por: Unai Caballero, et al.
Publicado: (2021)

Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males
por: Hui Liu, et al.
Publicado: (2021)

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study
por: Nazief AM, et al.
Publicado: (2020)

Progression of Aortic Calcification in Stage 4–5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation
por: Roosa Lankinen, et al.
Publicado: (2021)

Glycoinsulinemic parameters associated with vitamin D status in patients with chronic kidney disease undergoing dialysis therapy
por: Santos-Marreiro,Camila, et al.
Publicado: (2021)

Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
por: Saeed Alqahtani, et al.
Publicado: (2021)

Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs.
por: Katherine Kay, et al.
Publicado: (2013)